GSK-3183475

N/A

Report date: 2025/03/06 20:00:09
NME

Base Information

Drug NameGSK-3183475
Drug Alias NameBOS-475GSK-3183475
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsPlaque psoriasisPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A